ema glp-1 vision loss recommendation 2025 Possible Link Between RA Medications & Eye Health Meeting highlights from the Pharmacovigilance

The Role of [(18)F]FDG-PET/CT in predicting malignant transformation of plexiform neurofibromas in neurofibromatosis-1

Oral riboflavin versus oral propranolol in migraine prophylaxis: an open label randomized controlled trial

Verify the batch before you reconstitute Open the published lab results and confirm your lot against the COA on file

Perkovic V, Tuttle KR, Rossing P, Mahaffey KW, Mann JF, Bakris G, et al

In addition, at this time we cannot predict or estimate the impact any collaboration with Novo Nordisk and / or the impact any shift in our GLP-1 business may have on our future results, including revenue or EBITDA